RIGOL Technologies Directors Significantly Increase H Shareholdings to Demonstrate Confidence in Future Prospects
Key Highlights
- Directors Purchase 1.90% of Issued H Shares: Four executive directors, including Chairman Dr. Wang Yue, have acquired a total of 471,100 H shares, representing approximately 1.90% of the company’s total issued H shares.
- Personal Funds Used: The share purchases were made using the directors’ own funds, with no financial assistance provided by the company.
- Motivation: The directors cited strong confidence in the company’s future growth prospects and recognition of its intrinsic value as the reason for their purchases.
- Commitment to Stability: The move aims to help stabilize the company’s share price and support overall capital market stability.
- Potential for Further Increases: The directors have not ruled out the possibility of further increasing their shareholdings, subject to compliance with applicable laws and regulations.
- Ongoing Monitoring and Disclosure: The company pledged to continue monitoring the situation and fulfill all disclosure obligations as required.
Details for Shareholders and Investors
RIGOL Technologies Co., Ltd. has announced, on a voluntary basis, that its Chairman Dr. Wang Yue and three executive directors—Mr. Wang Ning, Dr. Sun Ningxiao, and Mr. Cheng Jianchuan—have collectively purchased 471,100 H shares through the secondary market. This transaction amounts to approximately 1.90% of the company’s issued H shares.
Notably, these purchases were funded entirely by the directors’ own resources, with RIGOL Technologies providing no financial assistance. The acquisitions demonstrate the board’s strong vote of confidence in the company’s business outlook and their belief in the value proposition for shareholders.
The directors explicitly stated that their actions are intended to support the company’s share price and contribute to the stability of the capital market. In addition, they left open the possibility of further increases in their holdings, should market conditions and regulatory requirements allow.
Shareholders and potential investors are advised to take note of this development, as insider purchases by directors frequently signal positive expectations for a company’s future and can be considered price-sensitive information. The company reiterated its commitment to timely and transparent information disclosure in accordance with relevant regulations.
The current board composition includes four executive directors (Dr. Wang Yue, Mr. Wang Ning, Dr. Sun Ningxiao, and Mr. Cheng Jianchuan) and three independent non-executive directors (Dr. Qin Ce, Dr. Liu Liansheng, and Ms. Xu Xu).
Shareholders are reminded to exercise caution when dealing in the company’s shares, as director share purchases can influence market perception and potentially affect share price performance.
Disclaimer
This article is for informational purposes only and does not constitute investment advice. Investors are advised to conduct their own research or consult a licensed financial adviser before making any investment decisions.
